Programme National Cohortes Maladies Rares

  RaDiCo a bénéficié d'une aide de l'Etat gérée par l'Agence Nationale de la Recherche au titre du programme Investissements d'avenir portant la référence ANR-lO-COHO-03-01

Nos projets internationaux

Liste des projets européens impliquant RaDiCo (Horizon 20202, autres) soumis à la Commission Européenne depuis 2014

We keep trying !!

 

1. PROJETS EUROPEENS EN PREPARATION / EUROPEAN BIDS UNDER PREPARATION

 H2020 Call HP-PJ-06-2016: RARE DISEASES - SUPPORT FOR ERNs' NEW REGISTRIES (published on Dec 23rd 2016)

RaDiCo is supporting several of the funded European rare diseases Reference Networks in the preparation of their proposal, to be submitted before March 21st 2017

 

2. PROJETS EUROPEENS SOUMIS, EN COURS D'EVALUATION / EC PROPOSALS SUBMITTED, UNDER EVALUATION

COST Open Call Collection OC-2016-2 :
  •            In december 2016, (re)submission of an improved MINDDS proposal (Maximising Impact of research in Neuro-Developmental DisorderS) as a COST action, coordinated by the University of Cardiff (H Arwood). This project integrates the RaDiCo-GenIDA cohort and the RaDiCo platform. Waiting for evaluation results in March 2017

 

 

 

3. PROJETS EUROPEENS SOUMIS MAIS NON RETENUS / EC PROPOSALS SUBMITTED BUT NOT SELECTED FOR FUNDING

COST OPEN CALL COLLECTION OC-2016-1 :         

  • In April 2016, submission of the MINDDS proposal (Maximising Impact of research in Neuro-Developmental DisorderS) as a COST action, coordinated by the University of Cardiff (H Arwood). This project integrated the RaDiCo platform. Total score: 52/65 (funding threshold 45)

 

H2020 SC1-PM-04–2016: Networking and optimising the use of population and patient cohorts at EU level – One-stage application.
  • A full 11 mo€ proposal called RaDiCo-Europe (Networking and Optimising the Use of Rare Disease Cohorts at the EU level) coordinated by Inserm-RaDiCo (J Weinbach) submitted in April 2016. Total score: 13/15 (very good)

 

H2020 PHC-14-2015: New therapies for rare diseases – Two-stage application.
  •         A stage 1 letter of Intent supporting RaDiCo-COBBALT (H Dollfus): EYE-CureCil coordinated by Inserm. Successfully passed stage 1 and invited in February 2015 to stage 2 submission in April 2015.
  •         A stage 1 letter of Intent supporting RaDiCo-EURBIO Alport (L Heidet / B Knebelmann): AlportCure coordinated by University Medicine Goettingen (Oliver Gross).
  •        A stage 1 letter of Intent supporting RaDiCo-ACoStill (S Georgin Lavialle / B Fautrel): INFLACURE Autoinflammatory syndromes (AIS) – Coordinated by the University of Liverpool, UK (Mark Turner). Submitted in February 2015.

 

H2020 PHC-03-2015: Understanding common mechanisms of diseases and their relevance in co-morbidities – Two-stage application
  •         A stage 1 letter of Intent supporting RaDiCo-IDMet (A Linglart / I Netchine): IDeal-EpiCure – coordinated by the Second University Napoli (Andrea Riccio). Successfully passed stage 1 and invited in February 2015 to stage 2 submission in April 2015.

 

 

H2020-MSCA-ITN-2016 - MARIE SKŁODOWSKA-CURIE ACTIONS - Innovative Training Networks (ITN)
    •           A full proposal for an ITN project supporting RaDiCo-IDMet (A Linglart / I Netchine): Train-ID (European Training Network on Imprinting Disorders) – coordinated by the Second University Napoli (Andrea Riccio) – Submitted in January 2015. Score: 81,4 / 100 (threshold: 70)

 

H2020-MSCA-ITN-2015 - MARIE SKŁODOWSKA-CURIE ACTIONS - Innovative Training Networks (ITN)
  •         A full proposal for an ITN project supporting RaDiCo-IDMet (A Linglart / I Netchine): IDeal-EpiTraining – coordinated by the Second University Napoli (Andrea Riccio) – Submitted in January 2015. Score: 88,4 / 100 (threshold: 70)
eRare E-Rare Joint Transnational Call for Proposals 2015 "Transnational Research Projects on Rare Diseases"
  •         A stage 1 Letter of Intent supporting RaDiCo-IDMet (A Linglart / I Netchine): ESPRIT (Epigenetic, Stratification, Phenomics and Recovery strategies towards Imprinting diseases diagnosis and Treatment) – coordinated by Inserm (A Linglart). Submitted in February 2015.
  •       A stage 1 Letter of Intent supporting RaDiCo-EURBIO Alport (L Heidet / B Knebelmann): EASI (European Alport Syndrome Initiative: harmonization and extension of a European database and biological bank for research and treatment of Alport syndrome) – coordinated by Inserm (L Heidet). Submitted in February 2015.
  •        A proposal supporting RaDiCo-ACOSTill (S Georgin Lavialle): ACOSA (European Adult and Childhood-onset Still Disease Alliance) – coordinated by Inserm-RaDiCo (S Amselem).  Successful stage 1 LoI submitted in February 2015. Stage 2 submitted in May 2015.